References
- Retnakaran A, Retnakaran R. Adiponectin in pregnancy: implications for health and disease. Curr Med Chem. 2012;19:5444–5450.
- Lu D, Yang X, Wu Y, et al. Serum adiponectin, leptin and soluble leptin receptor in pre-eclampsia. Int J Obstet Gynaecol. 2006;5:121–126.
- D’Anna R, Baviera G, Corrado F, et al. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders. Obstet Gynecol. 2005;106:340–344.
- Burton GJ, Jauniaux E. Oxidative stress. Best Pract Res Clin Obstet Gynaecol. 2011;25:287–299.
- Agarwal A, Aponte-Mellado A, Premkumar BJ, et al. The effects of oxidative stress on female reproduction: a review. Reprod Biol Endocrinol. 2012;10(49):1–31.
- Miehle K, Stepan H, Fasshauer M. Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol. 2012;76:2–11.
- Goldstein BJ, Scalia RG, Ma XL. Protective vascular and myocardial effects of adiponectin. Nat Clin Pract Cardiovasc Med. 2009;6:27–35.
- Takagi Y, Nikaido T, Toki T, et al. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch. 2004;444:49–55.
- Barazzoni R, Bernardi A, Biasia F, et al. Low fat adiponectin expression is associated with oxidative stress in nondiabetic humans with chronic kidney disease – impact on plasma adiponectin concentration. Am J Physiol Regul Integr Comp Physiol. 2007;293:R47–54.
- Indulekha K, Surendara J, Anjanaa RM, et al. Circulating levels of high molecular weight (HMW) adiponectin and total adiponectin in relation to fat distribution, oxidative stress and inflammation in Asian Indians. Dis Markers. 2012;33:185–192.
- Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302–310.
- Benzie IF, Strain JJ. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem. 1996;239:70–76.
- Vaiopoulos AG, Marinou K, Christodoulides C, Kouutilieris M. The role of adiponectin in human vascular physiology. Int J Cardiol. 2012;155:188–193.
- Lautamäki R, Rönnemaa T, Huupponen R, et al. Low serum adiponectin is associated with high circulating oxidized low-density lipoprotein in patients with type 2 diabetes mellitus and coronary artery disease. Metab Clin Exp. 2007;56:881–886.
- Fuglsang J, Skjaerbaek C, Frystyk J, et al. A longitudinal study of serum adiponectin during normal pregnancy. BJOG. 2006;113:110–113.
- Mazaki-Tovi S, Kanety H, Pariente C, et al. Maternal serum adiponectin levels during human pregnancy. J Perinatol. 2007;27:77–81.
- Eleuterio NM, Palei AC, Machado JSR, et al. Correlations between circulating levels of adipokines and anti-angiogenic factors in women with BMI <30 and a late-onset preeclampsia. Hypertens Pregnancy. 2014;33:72–80.
- Dalamaga M, Srinivas SK, Elovitz MA, et al. Serum adiponectin and leptin in relation to risk for preeclampsia: results from a large case–control study. Metab Clin Exp. 2011;60:1539–1544.
- Kurlak LO, Green A, Loughna P, Broughton FP. Oxidative stress markers in hypertensive states of pregnancy: preterm and term disease. Clin Transl Physiol. 2014;5:1–8.
- Gomes HF, Palei ACT, Machado JSR, et al. Assessment of oxidative status markers and NO bioavailability in hypertensive disorders of pregnancy. J Hum Hypertens. 2013;27:345–348.